Methyllycaconitine mla
Methyllycaconitine (MLA) is a natural product compound that functions as a potent and selective antagonist of the alpha7 nicotinic acetylcholine receptor. It is commonly used in scientific research to study the role of the alpha7 nicotinic receptor in various biological processes.
Lab products found in correlation
5 protocols using methyllycaconitine mla
Neurochemical Reagents for Cell Studies
Immunofluorescent Labeling of Neuronal Markers
Capsaicin and SB-366791 were purchased from Sigma-Aldrich. Methyllycaconitine (MLA) was from Abcam and dihydro-beta-erythroidine (DHBE), mecamylamine (MEC) picrotoxin, TTX, APV and CNQX were from Tocris. Recombinant Human TrkA Fc and TrkB Fc Chimera Proteins were from R & D Systems. All other reagents were from Carl Roth.
Nicotinic Receptor Signaling Pathway Protocol
Investigating α7nAChR Modulation in Neurotherapy
Pharmacological Modulation of Neuronal Receptors
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!